NI
NXTM

Numeric Investors’s NxStage Medical Inc. NXTM Stock Holding History

Numeric Investors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-29,400
Closed -$441K – 1242
2016
Q1 		$441K Buy
+29,400
New +$493K ﹤0.01% 746

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Numeric Investors's NXTM Position: Q2 2016 in Review

Numeric Investors sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 29,400 shares — an estimated $441K sold.

Numeric Investors first reported a position in NXTM in Q1 2016 and held it in 1 quarter. The position peaked at $441K in Q1 2016. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

  • Numeric Investors reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
  • Numeric Investors sold 29,400 NxStage Medical Inc. shares in Q2 2016, an estimated $441K.
  • Numeric Investors first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 1 quarter.
  • Numeric Investors's NxStage Medical Inc. position peaked at $441K in Q1 2016.
  • 147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on Numeric Investors's 13F filing for Q2 2016, filed 16 Aug 2016.